Cargando…
Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs
SARS-CoV-2 has evolved as several variants. Immunization to boost the Ab response to Spike antigens is effective, but similar vaccines could not enhance Ab efficacy enough. Effective Ab responses against the human ACE2 (hACE2)-mediated infection of the emerging SARS-CoV-2 variants are needed. We ide...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966687/ https://www.ncbi.nlm.nih.gov/pubmed/36851165 http://dx.doi.org/10.3390/vaccines11020287 |
_version_ | 1784897078849175552 |
---|---|
author | Watanabe, Yoshihiro Hosokawa, Natsuko Yoshida, Misaki Miura, Tomoyuki Kawano, Mitsuhiro |
author_facet | Watanabe, Yoshihiro Hosokawa, Natsuko Yoshida, Misaki Miura, Tomoyuki Kawano, Mitsuhiro |
author_sort | Watanabe, Yoshihiro |
collection | PubMed |
description | SARS-CoV-2 has evolved as several variants. Immunization to boost the Ab response to Spike antigens is effective, but similar vaccines could not enhance Ab efficacy enough. Effective Ab responses against the human ACE2 (hACE2)-mediated infection of the emerging SARS-CoV-2 variants are needed. We identified closed linear epitopes of the SARS-CoV-2 Spike molecule that induced neutralizing Abs (nAbs) against both S1-RBD, responsible for attachment to hACE2, and S2-HR1/2, in convalescents and vaccine recipients. They inhibited a pseudo-virus infection mediated by the hACE2 pathway. The epitope sequences included epitopes #7 (aa411-432), #11 (aa459-480) and #111 (aa1144-1161), in S1-RBD and S2-HR2. Epitope #111 was conserved in Wuhan and variant strains, whereas #7 and #11 were conserved in Wuhan carried mutations K417N and S477N/T478K in Omicron BA.4/5. These mutations were recognized by the original epitope-specific Abs. These epitopes in RBD and HR2 neither contained, nor overlapped with, those responsible for the antibody-dependent enhancement of the SARS-CoV-2 infection. The sublingual administration of multiple epitope-conjugated antigens increased the IgG and IgA Abs specific to the neutralizing epitopes in mice pre-immunized subcutaneously. The findings indicated that S1-RBD and S2-HR2 epitopes were responsible for pseudo-virus SARS-CoV-2 infections and that sublingual boosts with multiple epitope-conjugated antigens could enhance the protection by nAbs of IgG and IgA against infection by a wide range of variants. |
format | Online Article Text |
id | pubmed-9966687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99666872023-02-26 Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs Watanabe, Yoshihiro Hosokawa, Natsuko Yoshida, Misaki Miura, Tomoyuki Kawano, Mitsuhiro Vaccines (Basel) Article SARS-CoV-2 has evolved as several variants. Immunization to boost the Ab response to Spike antigens is effective, but similar vaccines could not enhance Ab efficacy enough. Effective Ab responses against the human ACE2 (hACE2)-mediated infection of the emerging SARS-CoV-2 variants are needed. We identified closed linear epitopes of the SARS-CoV-2 Spike molecule that induced neutralizing Abs (nAbs) against both S1-RBD, responsible for attachment to hACE2, and S2-HR1/2, in convalescents and vaccine recipients. They inhibited a pseudo-virus infection mediated by the hACE2 pathway. The epitope sequences included epitopes #7 (aa411-432), #11 (aa459-480) and #111 (aa1144-1161), in S1-RBD and S2-HR2. Epitope #111 was conserved in Wuhan and variant strains, whereas #7 and #11 were conserved in Wuhan carried mutations K417N and S477N/T478K in Omicron BA.4/5. These mutations were recognized by the original epitope-specific Abs. These epitopes in RBD and HR2 neither contained, nor overlapped with, those responsible for the antibody-dependent enhancement of the SARS-CoV-2 infection. The sublingual administration of multiple epitope-conjugated antigens increased the IgG and IgA Abs specific to the neutralizing epitopes in mice pre-immunized subcutaneously. The findings indicated that S1-RBD and S2-HR2 epitopes were responsible for pseudo-virus SARS-CoV-2 infections and that sublingual boosts with multiple epitope-conjugated antigens could enhance the protection by nAbs of IgG and IgA against infection by a wide range of variants. MDPI 2023-01-28 /pmc/articles/PMC9966687/ /pubmed/36851165 http://dx.doi.org/10.3390/vaccines11020287 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Watanabe, Yoshihiro Hosokawa, Natsuko Yoshida, Misaki Miura, Tomoyuki Kawano, Mitsuhiro Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title | Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title_full | Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title_fullStr | Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title_full_unstemmed | Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title_short | Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
title_sort | identification of closed linear epitopes in s1-rbd and s2-hr1/2 of sars-cov-2 spike protein able to induce neutralizing abs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966687/ https://www.ncbi.nlm.nih.gov/pubmed/36851165 http://dx.doi.org/10.3390/vaccines11020287 |
work_keys_str_mv | AT watanabeyoshihiro identificationofclosedlinearepitopesins1rbdands2hr12ofsarscov2spikeproteinabletoinduceneutralizingabs AT hosokawanatsuko identificationofclosedlinearepitopesins1rbdands2hr12ofsarscov2spikeproteinabletoinduceneutralizingabs AT yoshidamisaki identificationofclosedlinearepitopesins1rbdands2hr12ofsarscov2spikeproteinabletoinduceneutralizingabs AT miuratomoyuki identificationofclosedlinearepitopesins1rbdands2hr12ofsarscov2spikeproteinabletoinduceneutralizingabs AT kawanomitsuhiro identificationofclosedlinearepitopesins1rbdands2hr12ofsarscov2spikeproteinabletoinduceneutralizingabs |